Multiple Myeloma

Multiple Myeloma News

  • 'DaraLenDex' Combo Best for Relapsed/Refractory Multiple Myeloma The combination of daratumumab, lenalidomide and dexamethasone (DaraLenDex) appears to offer the best outcomes in patients with relapsed and/or refractory multiple myeloma (MM), according to a network meta-analysis involving 18 treatment options.
  • 'Strong Evidence': Obesity Tied to 11 Cancers An 'umbrella review' has found that excess body fat is associated with multiple cancers, mostly those of the digestive organs and hormone-related malignancies in women.

Multiple Myeloma Perspective